Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.8.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 90,495 $ 79,223
Short-term investments 316,826 86,873
Restricted cash - short-term 194 194
Prepaid expenses and other current assets 6,099 5,900
Total current assets 413,614 172,190
Property and equipment, net 58,194 44,129
Restricted cash - long-term 1,200 1,200
Other assets 100 260
Total assets 473,108 217,779
Current liabilities:    
Accounts payable 6,098 14,711
Accrued compensation 4,312 5,664
Accrued research and development expenses 6,336 4,006
Other current liabilities 4,303 3,265
Total current liabilities 21,049 27,646
Long-term liabilities 12,875 12,269
Total liabilities 33,924 39,915
Commitments and contingencies (Note 7)
Stockholders’ equity:    
Common stock—$0.0001 par value, 500,000 shares authorized as of March 31, 2018 and December 31, 2017; 43,893 and 30,730 shares issued and outstanding as of March 31, 2018 and December 31, 2017, respectively 4 3
Additional paid-in capital 777,797 474,662
Accumulated other comprehensive loss (524) (151)
Accumulated deficit (338,093) (296,650)
Total stockholders’ equity 439,184 177,864
Total liabilities and stockholders’ equity $ 473,108 $ 217,779